FDA Safety Warnings or Clinical Trial Findings on Tirzepatide As of 2024, the FDA has not issued a black box warning specific to Zepbound, but it shares the same class-wide warning found on other GLP-1 drugs like Wegovy and Ozempic: a potential link to thyroid C-cell tumors, including medullary thyroid carcinoma (MTC)
Arsenical air pollution and lung cancer
C.MalloF
The problem is that not only its a profit maximizing scheme, but also it impacts the premiums, because at the end of the day, what has happened is that as these institutions are overpaying for these medicines, and pharmaceutical industry is selling it at a much lower price
That kind of combination requires careful clinical oversight, but its a conversation worth having
For a novel compound like 5-amino-1MQ, microdosing could be an appropriate strategy, as it may provide insights into the compound's metabolism, biological activity, and safety profile